Veralto (NYSE:VLTO – Get Free Report) had its price objective decreased by research analysts at Stifel Nicolaus from $117.00 to $116.00 in a research note issued to investors on Friday,Benzinga reports. The firm presently has a “buy” rating on the stock. Stifel Nicolaus’ price objective would indicate a potential upside of 13.96% from the company’s previous close.
Other equities analysts have also issued reports about the company. Jefferies Financial Group initiated coverage on Veralto in a report on Thursday, December 12th. They set a “buy” rating and a $125.00 target price for the company. Citigroup decreased their price target on shares of Veralto from $118.00 to $116.00 and set a “neutral” rating for the company in a report on Monday, January 13th. BMO Capital Markets upped their target price on Veralto from $117.00 to $119.00 and gave the stock an “outperform” rating in a research report on Monday, September 30th. Finally, Royal Bank of Canada boosted their target price on shares of Veralto from $108.00 to $111.00 and gave the stock a “sector perform” rating in a research report on Friday, October 25th. Six investment analysts have rated the stock with a hold rating and five have issued a buy rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Hold” and an average target price of $113.18.
Read Our Latest Stock Report on Veralto
Veralto Trading Down 1.4 %
Veralto (NYSE:VLTO – Get Free Report) last issued its quarterly earnings results on Wednesday, October 23rd. The company reported $0.89 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.85 by $0.04. Veralto had a return on equity of 52.85% and a net margin of 15.69%. The firm had revenue of $1.31 billion for the quarter, compared to analyst estimates of $1.30 billion. During the same period last year, the company earned $0.75 EPS. The firm’s quarterly revenue was up 4.7% on a year-over-year basis. Equities research analysts expect that Veralto will post 3.48 EPS for the current year.
Insiders Place Their Bets
In other Veralto news, SVP Surekha Trivedi sold 752 shares of the firm’s stock in a transaction dated Friday, November 1st. The shares were sold at an average price of $102.91, for a total value of $77,388.32. Following the completion of the sale, the senior vice president now owns 10,413 shares in the company, valued at approximately $1,071,601.83. This trade represents a 6.74 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Insiders own 0.31% of the company’s stock.
Hedge Funds Weigh In On Veralto
Several large investors have recently made changes to their positions in VLTO. Ashton Thomas Securities LLC acquired a new position in Veralto in the third quarter valued at approximately $25,000. Goodman Advisory Group LLC acquired a new position in shares of Veralto in the 2nd quarter valued at $26,000. Raleigh Capital Management Inc. boosted its position in shares of Veralto by 692.3% in the 3rd quarter. Raleigh Capital Management Inc. now owns 309 shares of the company’s stock worth $35,000 after purchasing an additional 270 shares during the last quarter. Albion Financial Group UT grew its stake in shares of Veralto by 2,100.0% during the fourth quarter. Albion Financial Group UT now owns 352 shares of the company’s stock worth $36,000 after purchasing an additional 336 shares during the period. Finally, Geneos Wealth Management Inc. bought a new stake in Veralto in the fourth quarter valued at about $42,000. Institutional investors and hedge funds own 91.28% of the company’s stock.
Veralto Company Profile
Veralto Corporation provides water analytics, water treatment, marking and coding, and packaging and color services worldwide. It operates through two segments, Water Quality (WQ) and Product Quality & Innovation (PQI). The WQ segment offers precision instrumentation and water treatment technologies to measure, analyze, and treat water in residential, commercial, municipal, industrial, research, and natural resource applications through the Hach, Trojan Technologies, and ChemTreat brands.
Read More
- Five stocks we like better than Veralto
- Why Are Stock Sectors Important to Successful Investing?
- Bloom Energy: Powering the Future With Decentralized Energy
- Which Wall Street Analysts are the Most Accurate?
- Dividend Powerhouses: Blue-Chip Stocks Built for the Long Haul
- How to Plot Fibonacci Price Inflection Levels
- Why Traders Are Buying the Dip on Johnson & Johnson Stock
Receive News & Ratings for Veralto Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veralto and related companies with MarketBeat.com's FREE daily email newsletter.